FogPharma to Present at the 42nd Annual J.P. Morgan Healthcare Conference
CAMBRIDGE, Mass.–(BUSINESS WIRE)–FogPharma®, a clinical-stage precision medicine biopharmaceutical company committed to transforming the lives of patients... Read more.
Security Bank of Kansas City Expands Partnership with NCR Atleos to Transform Self-Service Banking
ATLANTA–(BUSINESS WIRE)–NCR Atleos Corporation (NYSE: NATL) (“Atleos”), a leader in expanding financial access for financial institutions, retailers... Read more.
Viridian Therapeutics to Webcast Presentation at the 42nd Annual J.P. Morgan Healthcare Conference
WALTHAM, Mass.–(BUSINESS WIRE)–Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biopharmaceutical company focused on discovering and developing potential... Read more.
Bruker Announces Acquisition of Tornado Spectral Systems to Expand Its Biopharma Process Analytical Technology (PAT) Product Portfolio
MISSISSAUGA, Ontario–(BUSINESS WIRE)–$BRKR #BRKR—Bruker (Nasdaq: BRKR) today announced the acquisition of Tornado Spectral Systems Inc., a Canadian... Read more.
NiKang Therapeutics Appoints Joanne Lager, M.D., as Chief Medical Officer
WILMINGTON, Del.–(BUSINESS WIRE)–NiKang Therapeutics Inc. (“NiKang”), a clinical stage biotech company focused on developing innovative small molecule... Read more.
Hungary Insurance Industry Governance, Risk and Compliance Report 2023 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Hungary Insurance Industry – Governance, Risk and Compliance” report has been added to ResearchAndMarkets.com’s... Read more.
AXA Digital Transformation Strategy Analysis Report 2023: Innovation Programs, Technology Initiatives, Estimated ICT Budget, Major ICT Contracts – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “AXA – Digital Transformation Strategies” company profile has been added to ResearchAndMarkets.com’s... Read more.
Tradeweb Reports December 2023 Total Trading Volume of $28.9 Trillion and Average Daily Volume of $1.46 Trillion
Month of December 2023 ADV up 43.3% YoY Fourth Quarter 2023 ADV up 56.9% YoY Full Year 2023 ADV up 27.6% YoY NEW YORK–(BUSINESS WIRE)–Tradeweb Markets... Read more.
Cybin Highlights Recent Topline Results and Outlines Key Upcoming Milestones Across its Clinical Development Programs
– Recently announced positive Phase 2 topline data in Major Depressive Disorder (“MDD”) with 79% of patients in remission from depression after two doses... Read more.
OBIO® Celebrates the Advancement of Women in Health Science with WiHI Seed Program and Leadership Awards
TORONTO–(BUSINESS WIRE)–The Ontario Bioscience Innovation Organization (OBIO®) is proud to announce significant milestones for its Women in Health Initiative... Read more.